PTC Therapeutics' (PTCT) "Maintains" Rating Reiterated at 1-800-FLOWERS.COM
1-800-FLOWERS.COM reiterated their maintains rating on shares of PTC Therapeutics (NASDAQ:PTCT – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. Other research analysts also recently issued research reports about the stock. Royal Bank of Canada upped their price objective on shares of PTC Therapeutics from $44.00 to $51.00 in a […]